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Abstract 
Mineral Trioxide Aggregate (MTA), a relatively new material, has been widely 
used for root-end fillings, pulp capping, perforation repairs and other endodontic 
procedures . Many studies have reported the biocompatibility of MTA in vitro and 
in vivo. Previous studies have shown that MTA provides a biologically active 
substrate for bone cells , stimulates interleukin production, and that osteoblasts 
have a favorable response to MTA as compared with IRM and amalgam (Koh et 
al. 1998; Zhu et al. 2000) . 
V 
In this in vitro study a modification was made to conventional MTA (modified 
MTA), with the addition of Silicon (Si). The effects of MTA and modified-MTA, on 
cell attachment efficiency, cell proliferation rate, alkaline phosphatase activity and 
osteocalcin expression were compared. Human osteoblast-like cells derived 
from healthy alveolar bone explants were used and grown to second passage in 
order to perform these experiments. 
Human osteoblast-like cells were grown and cultured in 24 well plates, in the 
presence of MTA, modified-MTA and control (plastic culture dish, PCD). Cells 
were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 
F-12 nutrient mixture, fetal bovine serum (FBS), penicillin G (5000 
U/ml)/streptomycin sulphate (5000 µg/ml), and 250 µg/ml Amphotericin 8. Cells 
were cultured for periods of 12 and _20 days. MTA and modified-MT A were 
mixed according to manufacturer's instructions and made into 15.5 mm in 
diameter, 1.5 mm thickness discs and allowed to set for a period of 24 hours at 
37°C, 5%CO 2 , and 100% humidity. Before the 1 ih and 20th day, differentiation 
medium containing vitamin D3 was added to the cell cultures, a period of 48 
hours before the day the experiment was conducted. Observation of pH was 
made throughout the duration of the culture. Cell attachment and proliferation 
rate were determined by measuring the optical density of crystal violet dye in 
fixed culture cells. Alkaline phosphatase activity was determined by measuring 
the optical density of released p-Nitrophenol from a fixed cellular layer. 
VI 
Osteocalcin expression was determined by measuring 1125- labeled antibody in 
extracted culture media. All data was normalized on per 104 or 105 cells basis. 
One-way analysis of variance (ANOVA) and a two sample t-test assuming equal 
or non-equal variance were used for statistical analysis on the data. 
The mean pH of the culture medium cultured in the presence of MTA, modified -
MTA, and control decreased over 18 days of culture with a slight increase around 
20 days. There was no significant difference between osteoblast cells grown in 
the presence of MTA, modified-MTA, and control regarding cell attachment 
efficiency at 16 hours. At 12 and 20 days, attachment and proliferation rate was 
significantly higher with the MTA and modified-MTA groups, but there was no 
significant difference between them. At 12 and 20 days, the control group of 
osteoblast cells had higher ALP activity than the MTA and modified-MT A group. 
At 20 days, MTA and modified-MT A expressed higher amounts of osteocalcin 
than the control group. Based on the results of this in vitro study , MTA and 
modified-MTA are both capable of stimulating osteogenic effects in normal 
human osteoblast cultures. This study demonstrated the role of silicon in 
stimulating osteogenesis of normal human osteoblast cells. 
Further studies need to be conducted in order to evaluate better modifications of 
conventional MTA in order to evaluate the favorable response from human 
osteoblast cells in contact with the material. 
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INTRODUCTION 
1 
Introduction 
There are clinical situations in the field of Endodontics that are challenging and in 
which the prognosis is guarded due to the complexity of the situation. 
Specifically, such situations can be: surgical treatment of endodontic failure, 
iatrogenic perforations of the lateral wall or furcation area, persistent pulpal and 
periradicular pathosis, and internal and external resorption. There have been 
many materials and techniques in dentistry that served to address the 
aforementioned challenges. However, most materials that are available lack the 
biological or physical properties that are necessary for successful treatment of 
such cases. 
In order to address the need for the improvement of materials that cater to the 
restoration of certain clinical situations, thorough investigation of an array of 
materials have been conducted through both in vitro and in vivo studies in order 
to find a material that brings about the optimal treatment--to seal the root canal 
systems and provide a biocompatible environment for the healing of the 
surrounding periradicular tissues. The pursuit of the ideal filling material 
continues to be an area of interest among researchers and clinical investigators. 
The main objective of a. root-end filling material is to provide an apical seal that 
prevents the movement of bacteria and bacterial by-products from the root canal 
system into periradiuclar tissues . According to Gartner and Dorn (1992) an ideal 
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root-end filling material should have these properties: easy to manipulate, 
radiopaque, dimensionally stable, nonabsorbable, insensitive to moisture, 
nontoxic, and biocompatible. In addition, the retrofilling material should permit 
healing of the periradicular tissue in an ideal manner via the regeneration of 
cementum, periodontal ligament, and alveolar bone. 
Materials that have been advocated for use as retrofilling material include: 
amalgam, composite resin, super-EBA cement, glass-ionomer cement, 
polycarboxylate cements, Gavit and gutta-percha (Friedman S et al., 1997). 
These materials are usually placed in direct contact with the periodontium for a 
prolonged period of time; therefore their biocompatibility is of primary importance. 
Surgical endodontic therapy has become the treatment of choice regarding the 
retreatment of endodontic failures. The procedure involves exposing the 
involved apex of the root, resecting the root-end, and sealing the apical foramen 
with a root-end filling material. The purpose of a root-end filling material during 
periradicular surgery is to create a three dimensional seal of the root canal 
system from the leakage of irritants and bacterial products, and for that seal to be 
biocompatible with the surrounding periradicular tissue. 
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A material called mineral trioxide aggregate (MTA), a recently introduced cement, 
has been developed at Loma Linda University. It has a variety of potential uses 
including: root-end filling material, root perforations repairs, apexification and 
apexogenesis, to name a few. There have been several reports of its superior 
biocompatibility with periodontal tissue (Torabinejad, M. et al., 1995, 1997), 
excellent sealing ability in the presence of moisture (Torabinejad, M. et al., 1993, 
1994), and that it provides appropriate mechanical properties as an apical 
sealing material (Torabinejad, M. et al., 1995). The in vitro and in vivo studies on 
MTA have encouraged many clinicians to consider and use MTA as a root end 
filling material and as a material suitable for repairing perforations and performing 
apexifications. 
Recent in vivo studies have demonstrated that the element Silicon released as 
ions from materials such as bioactive glass serve to signal and selectively 
stimulate osteogenic activity. Regulation of osteogenic activity may occur at 
more than one level, from DNA transcription to the activity of the final end 
products of protein synthesis (Chou, L. et al., 1995). In addition, higher 
concentrations of Silicon-containing bioactive glass generated greater amounts 
of woven bone and cartilage than bioactive glass that contained lower levels of 
Silicon. Based on this study, Silicon was proposed as a key element in 
stimulating osteogenesis and may influence osteogenic activity (Chou, L. & AI-
Bazie, S., 1998a) . It has been proven that Silicon ions in physiologic solution 
may play a major role in the regulation of osteogenic behavior (Keating, PE et al., 
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1992). It has been shown that high levels of Silicon in combination with calcium 
and phosphorus can produce significantly higher levels of cell proliferation, 
alkaline phosphatase activity, osteocalcin expression and mineralization of 
human osteoblast cells (Lyu, K. & Chou L., 1999). 
Since Silicon has been investigated and shown to have a major role in the 
regulations of osteogenic behavior, the modification of MTA with the addition of 
Silicon is of interest to observe whether the modified material can influence and 
enhance existing osteogenic properties and cell behavior when compared to 
MTA alone. Therefore, the goal of this study is to evaluate the effects of Silicon 
in combination with mineral trioxide aggregate (MTA) on the osteogenic activity 
of normal human osteoblast cell cultures. 
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LITERATURE REVIEW 
6 
Basic Bone Biology 
Bone is a specialized form of connective tissue that is composed of two major 
components: a group of specialized bone cells and an extracellular matrix. The 
specialized group of bone cells originates from two cell lines: the mesenchymal 
stem cell line and the hematopoietic stem cell line. The osteoblast, involved in 
bone formation, is derived from the mesenchymal cell line. The monocyte and 
osteoclast, involved in bone resorption, are derived from the hematopoietic cell 
line. These cells occupy a very small portion of the total volume of bone, 
however, they perform critical roles in the generation and regulation of the 
mineralized matrix. The extracellular matrix is primarily composed of collagen 
and an inorganic mineral phase such as hydroxyapatite. Type I collagen is 
predominantly found in bone, occupying 90% of the total organic matrix 
(Buckwater, J.A. et al., 1996a). 
Osteoblastic Lineage 
The osteoblast lineage begins with the mesenchymal stem cell, which is self-
renewing and highly proliferative. The mesenchymal stem cell line can 
differentiate into four unique cell types: osteoblasts, fibroblasts, chondroblasts 
and adipocytes. The next cell following the stem cell is the osteoprogenitor cell. 
Osteoprogenitor cells are capable of undergoing asymmetric division to produce 
differentiated or predifferentiated c~lls. They are regarded as the reserve cells 
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that can be stimulated to transform into osteoblasts. They have the capacity to 
divide and proliferate and function to provide nutritional support for the 
osteocytes in the bone matrix. The preosteoblast follows after the 
osteoprogenitor cell. It is a transitional state of 2 to 3 days in which proliferative 
activity and an increase of osteoblastic phenotype is expressed (Aviolo, E.F. & 
Krane, S.M., 1990). Preosteoblasts possess intracellular alkaline phosphatase, 
receptors for 1 ,25-dihydroxyvitamin D3 and parathyroid hormone and are capable 
of mitotic division (McCarthy, E.F. & Frassica, F.J., 1990). 
Osteoblasts are bone-forming cells that produce osteoid and form calcified 
tissues in vivo. The osteoblast is a polarized cuboidal cell that measures 
between 20 to 30 µm. Osteoblasts secrete collagen and extracellular matrix on 
one side of the cell layer only. The most apparent function of osteoblasts is the 
synthesis and secretion of the organic matrix of bone. Local growth factors such 
as Transforming Growth Factor~ (TGF-~) and Bone Morphogenic Proteins 
(BMPs) signal the stem cells to further differentiate into osteoblast cells 
(McCarthy, E.F.& Frassica, F.J., 1990). Products of osteoblasts include: Type I 
collagen, osteocalcin, osteopontin, and bone sialoprotein. These cells may also 
have a role in controlling electrolyte fluxes and may influence the mineralization 
of bone matrix through the synthesis of organic components of bone and the 
production matrix vesicles. 
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When osteoblast cells become embedded into the mineralized matrix , they 
become osteocytes. Osteocytes are responsible for maintaining the bone matrix. 
Osteocytes communicate through intercellular gap junctions and cytoplasmic 
extensions (Sodek , J. & Berkman, F.A., 1987). They are rounded cells with an 
oval nucleus and scantily dispersed cytoplasm. They reside in the lacunae. 
They possess long cytoplasmic processes that radiate from the cell body through 
the canaliculi in the mineralized bone. These processes form to connect to other 
processes of osteocytes by gap junctions and connect to lining cells. The 
osteocytes and lining cells form a vast network of cell-to-cell connection known 
as the osteocytic membrane system. 
The osteocytic membrane system is important in the regulation of calcium ion 
flow in and out of the cell and the transmission of electrical signals in the bone. 
This enables the maintenance and balance of bone remodeling in areas of stress 
and strain. 
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Bone Extracellular Matrix 
Bone extracellular matrix (ECM) is the organic framework of bone. It is 
composed of 90% Type I collagen fibers (Buckwater, J.A., 1996a) which are the 
source of strength for the tissues and provides an inorganic mineral structure. 
The extracellular matrix also contains: elastin, proteoglycans, structural 
glycoproteins and noncollagenous proteins. Noncollagenous proteins consist of 
cell attachment proteins such as: fibronectin, osteonectin, osteopontin, bone 
sialoprotein, and osteocalcin . These proteins play a crucial role in bone cell 
attachment, movement, signaling, and mineralization processes. In addition, 
growth related proteins such as Transforming Growth Factors (TGF) and Insulin-
like Growth Factors (IGF) are also found in the extracellular matrix. Therefore, 
the organization of the extracellular matrix is important in the metabolism and the 
interactions within and among bone cells. The ECM also plays an important role 
at the cell surface in order to provide adhesion and interaction between other cell 
extracellular matrixes (Hay, E.D., 1991). 
The maturation and organization of the extracellular matrix contribute to the 
cessation of osteoblast cell proliferation. The extracellular matrix promotes 
expression of genes that make the matrix competent for mineralization and leads 
to the expression of the mature osteoblast phenotype. 
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Sequence of Osteoblast Differentiation 
There are four stages within osteoblast development. The first stage, the 
preconfluent proliferation stage, consists of the biosynthesis and activation of 
Type I collagen and the enlargement of the osteoblast cell population. Genes 
that are associated with the formation of the extracellular matrix are actively 
expressed and gradually down regulated. 
The second stage, the post confluent stage, is associated with the organization 
and maturation of the extracellular matrix during which post-confluent genes are 
actively expressed. The activities of proteins related to the osteogenic 
phenotype (e.g. Alkaline phosphatase) and mRNA increase by ten fold. During 
this stage, the extracellular matrix undergoes a series of modifications in 
preparation for mineralization. 
The third stage involves the deposition of hydroxyapatite through signaling of 
gene expression, and osteopontin and osteocalcin exhibit maximal expression. 
As the cell progresses to the mineralization stage, alkaline phosphatase activity 
is increased. As the culture progresses into the mineralization stage, all cells 
express alkaline phosphatase. However, in heavily mineralized cultures, cellular 
levels of alkaline phosphatase and its mRNA levels decrease. The collagenase 
gene is activated to a maximal level. As the cells enter the mineralization stage, 
other bone related proteins such as bone sialoprotein, osteocalcin, and 
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osteopontin are up-regulated. The amounts of these proteins respond to the 
accumulation of minerals (Owen, T.A. et al., 1990). During active proliferation, 
osteopontin is expressed, and is down regulated after proliferation. Osteocalcin 
is expressed only during post proliferation with onset of nodule formation (Lian, 
J.B. et al., 1978). 
In the final stage, there is increased collagenase, elevated Type I collagen gene 
expression, apoptotic activity and compensatory proliferation activity, shrinkage 
of the cell, membrane blebbing, chromatin condensation, and nuclear 
fragmentation (Stein GS et al., 1996). 
The Significance of Osteoblast Cells 
The location, histochemistry and morphology of osteoblasts verify that the cells 
are actively engaged in the production and secretion of the components of the 
bone matrix. Osteoblasts take in amino acids, glucose and sulfate to 
manufacture collagen, mucopolysaccharides and glycoproteins that are secreted 
into the organic part of bone matrix. 
Type I collagen makes up 95% of the organic matrix in bone and is responsible 
for 65% of the total protein synthesis in bone forming cells (Avioli, E.F. & Krane, 
S.M., 1990). Osteoblasts also synthesize noncollagenous proteins, such as 
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osteocalcin, which amounts to 1 % to 2% of the bone protein in all vertebrates. 
Osteocalcin is referred to as the bone gamma-carboxyglutamic acid containing 
protein (BGP). The exact function of osteocalcin is unknown, however, the 
gamma-carboxyglutamic acid residues allow the protein to firmly bind 
hydroxyapatite and calcium. 
Another noncollagenous protein that is expressed abundantly by osteoblasts is 
osteonectin, a secreted protein that is acidic and rich in cysteine. It is a 
phosphoprotein that binds strongly to hydroxyapatite as well as collagen. It is 
expressed in other tissues that undergo active remodeling. The function of 
osteonectin is not known, however, in patients with osteogenesis imperfecta, 
there is a decreased expression of osteonectin. Osteonectin is not an exclusive 
_ bone protein, and is found in platelets as well (Avioli, E.F. & Krane, S.M., 1990). 
Other noncollagenous proteins are expressed in the bone matrix synthesized by 
osteoblasts. They are: osteopontin also known as bone sialoprotein, 
phosphoprotein , small proteoglycans, bone morphogenic proteins and bone 
derived growth factors . 
An important characteristic of osteoblasts is the production of alkaline 
phosphatase. It is a glycoprotein that is localized in the plasma membrane of 
osteoblast cells. Alkaline phosphatase is a predominant enzyme that is 
associated with osteoblastic differentiation. This enzyme is recognized as an 
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osteoblastic marker. Its levels are elevated in calcifying cartilage and dentin, and 
it is essential for mineralization. Total circulating alkaline phosphatase is also 
derived from the liver, intestine, spleen, kidney, placenta (during pregnancy) and 
from various tumors. Bone alkaline phosphatase comprises approximately 50% 
of the total circulating alkaline phosphatase in normal, healthy individuals. 
Alkaline phosphatase is used to check for the possibility of bone disease or liver 
disease due to an elevated serum alkaline phosphatase level. Elevated serum 
alkaline phosphatase can be due to rapid growth of bone since it is produced by 
osteoblast cells. The main action of alkaline phosphatase is the hydrolysis of p-
nitrophenol phosphate by the enzyme to yield p-nitrophenol and inorganic 
phosphate. 
Markers for Bone Formation 
The principle cells that mediate the bone-forming process of human skeletons 
are stromal osteoprogenitor cells that contribute to maintaining the osteoblast 
population and bone mass (Baron, R., 1996). The process of osteoblast 
differentiation has been well studied over the past three decades. This process 
is characterized by the identification of the proteins secreted by osteoblasts and 
other cells associated with the bone extracellular matrix during bone formation. 
Active osteoblasts can be characterized by the production of certain products 
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such as: Type I collagen, osteocalcin, osteopontin, alkaline phosphatase and 
bone sialoprotein. 
Osteoblast differentiation is marked by an increase synthesis of Type I collagen, 
alkaline phosphatase activity, and elevated osteocalcin expression upon 
exposure to 1,25-dihydroxyvitamin D3. During bone formation, production of 
Type I collagen and osteocalcin is increased in the presence of matrix 
mineralization. 
Type I collagen 
Type I collagen is the most abundant protein of the organic matrix of bone. It is 
considered the first marker of bone formation due to its abundant synthesis by 
osteoblast cells. Type I collagen is considered to be the structural framework of 
the mineralized matrix of bone. 
Osteocalcin 
Osteocalcin is a protein, which is also known as a bone Gia protein (BGP) and is 
found exclusively in bone tissue. It is a 49 residue polypeptide (58 kDa) and is 
highly conserved between species. In humans, the osteocalcin gene is located 
on chromosome 1 and is regulated at the transcriptional level by 1,25-
dihydroxyvitamin D3. It is a vitamin K and vitamin D dependent protein produced 
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by osteoblasts and is the most abundant and most widely studied of the non-
collagenous proteins in bone. It contains three gamma-carboxyglutamic acid 
residues, which allow the protein to firmly bind calcium and hydroxyapatite. It 
accounts for 10-20% of the noncollagenous protein in bone. While the in vivo 
function of osteocalcin is unknown, its affinity for bone mineral constituents 
implies a role in bone formation. The majority of osteocalcin secreted by the 
osteoblast is deposited in extracellular matrix. Serum osteocalcin represents the 
fraction of total osteocalcin that has not adsorbed to hydroxyapatite. It reflects 
the 10-40% of osteocalcin produced that is not incorporated into the bone matrix. 
Also, the expression rate in the osteoblast development sequence suggests that 
osteocalcin is a marker of the mature osteoblast. This is consistent with the fact 
that osteocalcin binds with minerals during bone formation (Lyu, K., 1999). 
Maximal levels of osteocalcin synthesis reach a peak that is slightly later than 
alkaline phosphatase activity. Therefore, osteocalcin may function during the 
later stages of extracellular matrix deposition and bone turnover rather than by 
promoting mineralization during initial stages of extracellular matrix deposition 
(Owen, T.A . et al., 1990). 
Many immunoassays have been developed to detect human osteocalcin. Bovine 
osteocalcin is more abundant and more stable than human osteocalcin, 
therefore, many assays are directed against bovine osteocalcin. There are 
several immunoassays available to detect osteocalcin: radioimmunoassay (RIA), 
immunoradiometric assay (IRMA) and enzyme immunoassay (ELISA). In some 
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assays, the procedure measures the amount of osteocalcin synthesized by bone 
cells. In others, the assay measures the amount of degraded osteocalcin in the 
serum. The IRMA developed the use of different antisera that cross-react with 
human osteocalcin. In histomorphometric analysis, the amount of circulating 
osteocalcin is positively correlated with parameters of bone turnover and bone 
formation. 
Alkaline phosphatase 
Alkaline phosphatase (ALP) is an enzyme synthesized by a number of tissues 
and is found throughout the body. This bone-specific isoenzyme is produced by 
osteoblasts and localized in the plasma membrane. The serum activity of this 
isoenzyme correlates with the bone formation rates determined by bone 
histomorphometry (Eastell et al. 1988) . The alkaline phosphatase molecules 
produced in bone, lever, and kidney are all formed from an identical gene product 
and the three types differ only in their post-translational carbohydrate 
modifications (Peel & Eastell 1993). If large amounts of alkaline phosphatase 
are present, it may signify bone or liver disease, or the presence of a tumor. 
Alkaline phosphatase has been long recognized as an osteoblast marker with 
high levels present in calcifying tissues like cartilage and dentin. This enzyme 
has limited specificity and cleaves organophosphate bonds and participates in 
the process of mineralization (Avioli EF & Krane SM, 1990). The common form 
17 
of alkaline phosphatase is a cell membrane associated form, expressed by liver, 
bone, and placenta from a single gene (Eyre DR, 1997). The main function of 
alkaline phosphatase in bone seems to be in generation of phosphate ions and in 
the transport of substances from intracellular compartments across the 
membrane into the extracellular region. In mineralization, alkaline phosphatase 
increases the local concentration of inorganic phosphate by carrying local 
phosphorus, but its exact role is not well understood (Bellows CG, 1991 ). 
Another area in which alkaline phosphatase may be involved is the breakdown of 
pyrophosphate, which is an inhibitor of calcium phosphate deposition at the 
extracellular level. 
Many studies have confirmed the stimulation of alkaline phosphatase expression 
by 1,25- dihydroxyvitamin D3 (Dietrich JW et al., 1976). This may explain the role 
of osteoblasts in physiologic regulation of the balance between bone formation 
and bone resorption (Sodek J & Berkman FA, 1987). Earlier studies have 
suggested that alkaline phosphatase is expressed in the differentiation stage of 
the osteoblast cells prior to the expression of osteocalcin (Mulkins MA et al., 
1983; Kurihara N et al., 1986; Beresford JN et al. 1986). 
It is widely accepted that ALP plays a role in the regulation of osteoblast 
differentiation. Although the physiologic role of ALP is not well known, it has 
been shown that when the number of bone cells increases to a more 
differentiated state, ALP activity levels change. Various studies have shown that 
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ALP is expressed prior to the expression of osteocalcin during the differentiation 
stage of the osteoblast cells. The level of ALP produced by osteoblast cells is 
routinely used for in vitro experiments as a bone marker of osteoblast 
differentiation (Owen TA et al., 1990). 
The Human Osteoblast Cell Phenotype 
Numerous in vitro studies have been conducted to examine the osteoblastic 
phenotype using osteosarcoma cell lines. OHS-4, SAOS-2, MG-63, AND HOS 
are examples of human osteosarcoma cell lines that are commonly used in 
research. Osteosarcoma cell lines are relatively easy to purchase and the 
growth and maintenance is simpler than harvesting a normal human osteoblast 
cell line. Osteosarcoma cells have the 1 ,25-dihydroxyvitamin 0 3 receptor, 
however, their osteogenic expressions are not comparable with normal human 
osteoblast cells (Mahonen A, et al., 1990). 
The history of culturing normal human osteoblast cells begins with Koshihara 
who, in 1987, used periosteum specimens of femur bone from a 20 year-old 
male to harvest human osteoblast-like cells. The findings of that study reported 
successful mineralized tissue formation from the cell line that was derived from a 
human explant bony tissue source. The formation of hydroxyapatite detected by 
electron probe microanalyzer showed a Ca/P ratio at 2.06 ± 0.25. This is close 
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to the 2.19 value of standard hydroxyapatite crystals. The cells derived from the 
explants were revealed to be osteoblastic cells. Additionally, in response to 
treatment with hormone, the cells produced detectable minerals from day 45. 
Mineralization was enhanced and the time taken was shortened to 30 days by 
the addition of a-glycerophosphate-Na (2mM) from the time of confluent growth. 
1 ,25-dihydroxyvitamin 0 3 was added in the presence of a-glycerophosphate 
sodium salt (2mM) for 21 days from confluence at 10-9 to 10-7 M concentrations 
(pharmacological dose). Upon this addition ALP activity increased 1.6 times, 
calcium 2.6 times, and phosphorus 1.9 times. The Ca/P ratio became closer 
from 2.23 (10-9 M) to 2.29 (10-8 M) upon the addition of 1,25-dihydroxyvitamin 0 3 
whereas the control Ca/P ratio was 1 .68. This demonstrated that 1 ,25-
dihydroxyvitamin 0 3 enhanced maturation of the hydroxyapatite of this cell line 
(Koshihara Y, 1987). Another study with human osteoblast culture harvested 
from trabecular bone showed a ten-fold increase in osteocalcin and 50% 
increase in ALP activity after 48 hours of treatment with 1,25-dihydroxyvitamin 0 3 
(Ericksen EF et al. 1988). 
There are other findings from human bone cell cultures established by 
collagenase-treated bone fragments in low Ca2+ medium. There were higher 
levels of ALP and increased intracellular cAMP after treatment with human 
parathyroid hormone. These cells formed thick extracellular matrices, which 
were mineralized upon treatment with calcium, fresh ascorbic acid, and 10 mM ~-
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glycerol phosphate. These cells also produced Type I collagen and osteonectin 
(Robey PG & Termine JD, 1985). 
Osteoblast Culture Technique 
The isolation of bone cells and the technique used in their culture should facilitate 
the separation and growth of osteoblast cells. There are several methods 
generally employed to harvest osteoblast cells. They are: mechanical, 
enzymatic, and explant procedures (Sodek J & Berkman FA 1987). The 
mechanical isolation method modified from Ecarot-Charrier B (1988) is based on 
the ability of osteoblasts to migrate from bone onto glass fragments. It is used 
with frontal and parietal bone from calvaria of 5 - 6 day-old mice. The enzyme 
isolation method, modified from Rao LG et al. (1977) uses a bacterial 
collagenase-rich protease mixture to perform a timed release of cells from the 
bone surface. P.G. Robey & J.D. Termine (1985) used this method on normal 
human bone obtained from two 63 year old patients during corrective surgery. 
Bone is placed in serum-containing nutrient medium. If it is kept at 4°C it can be 
used up to 24 hours later . The trabecular surface is exposed with bone cutters 
and cleaned of clinging marrow by washing with nutrient medium and forced 
suctioning with Pasteur pipette. Bone is then scraped, minced and washed 
extensively with nutrient medium without serum to remove blood components. 
Then the bone samples are incubated in the same serum-less medium with 
1 mg/ml of crude collagenase at 37°C on a rotator. Two hours later, supernatant 
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containing collagenase-released cells is removed and combined with medium 
containing 20% heat-inactivated fetal bovine serum, centrifuged and plated at low 
density into 35mm dishes. A complete medium, 1: 1 Dulbecco's Modified Eagle's 
Medium and Ham's Formula 12 with 20% heat-inactivated fetal bovine serum, 
100 units/ml of penicillin with the addition of 100 µg/ml streptomycin sulphate, 5 
µg/ml each of insulin and Selenium is used. Fibroblastic cells in the outer layer 
are released first with osteoclasts whereas osteoblasts in the inner layer are 
released later by the collagenase treatment (Sodek J & Berkman FA 1987). 
The explant procedure is based on the fact that bone cells that are allowed to 
grow out from bone explants will retain osteoblastic properties on subsequent 
culture. Trabecular fragments obtained from biopsy or surgery are washed in 
sterile phosphate-buffered saline (PBS) to remove blood and marrow 
components. Particles 3-5mm in diameter are prepared by dissection and placed 
in 90-mm tissue culture dishes with 0.2-0.6g bone per dish. They are treated 
with bacterial collagenase to remove any fibroblastic cells and undifferentiated 
osteoblastic cells. The bone explants are cultured at 37°C in 95% air, 5% CO2 
with 5-10 ml a-MEME supplemented with 10% FBS plus 50 U/ml penicillin, 15 
µg/ml streptomycin and 2 mM glutamine. Medium is changed after the first 24 
hours and subsequently at 5-day intervals. Outgrowths of cells from bone 
fragments appear within 1 week. These cells will develop a confluent monolayer 
at 3-4 weeks. After removing the bone explants, the confluent cells are 
trypsinized by the addition of 5 ml 0.01 % trypsin in citrate-saline. Within 5 
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minutes at 37°C the cells are detached by shaking the flask and combined with 
an equal volume of medium supplemented with 10% FBS to stop the trypsin 
activity. After collection by centrifugation at 400g, cells are washed with fresh 
medium prepared as above, dispersed by repeated aspiration through a 19-
guage needle, and plated in 35-mm tissue culture dishes at 5 x 104 cells/dish 
(Sodek J & Berkman FA, 1987). First subcultures of the cells from various types 
of bone resuspend parathyroid hormone (PTH), express high ALP levels, and 
synthesize high levels of collagen and osteocalcin. Their production is also 
regulated by 1 ,25-dihydroxyvitamin D3. The time to reach confluence is 
dependent on the age of the patient. Human osteoblasts maintain their 
phenotype through at least two passages (Eriksen EF et al., 1988; Harris SA et 
al., 1995). 
Silicon and Osteogenicity 
Silicon (Si) has been identified as a nutritional element only recently, in spite of 
being one of the most abundant molecules in the earth. It was found in 
mammalian osteoid tissue and connective tissue (Carlisle EM, 1981). It has a 
major structural role in diatoms, algae, radiolarians, sponges and several 
vascular plants by silification (a biomineralization where soluble silicate is 
polymerized intro structural components of the cell). There is a suggestion of an 
evolutionary connection between silification, matrix biosynthesis, and the 
calcification process (Simpson TL & Volcani BE, 1981 ). 
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Silicon is an essential metabolite of eukaryotic cells and organisms and is a 
dietary essential (Carlisle EM 1975). In rats, Silicon plays a role in the hormonal 
mechanism of ovulation physiology, linked with endocrine balance and mineral 
metabolism (Charnot Y & Asseko MC, 1977). There are inter-relations with 
Silicon, Calcium, and hormones in the manner of inhibition and promotion of 
calcification in mammals (Schwarz K 1973; Carlisle EM, 1982). Several human 
disorders (eg. Fibrotic lung disease, silicosis, pneumoconiosis, asbestosis, and 
esophageal cancers) are also related to Silicon. 
Localization of Silicon has been demonstrated in the bone of young rats and 
mice. Silicon-containing granules in the mitochondria of rat, liver, kidney, spleen, 
and osteoblast cells and the uptake of silicic acid by rat liver mitochondria were 
demonstrated (Carlisle EM 1975, Mehard CW, 1976; Johnson RN & Volcani BE, 
1978). Also, Silicon is known to be required for the normal formation of 
glycosaminoglycans in bone and cartilage and is essential for the development of 
mesenchymal embryonic tissue and the early stages of calcification (Carlisle EM, 
1976). It participates to the formation of cross-links between collagen and 
proteoglycans during bone formation. In addition it is abundant in adult 
connective tissue. It is present as an organic compound in polyuronides, and 
silicic acid-binding polysaccharides with proteins (Schwarz K, 1973; Hott M, 
1993). Silicon in glycosaminoglycans and polyuronides is covalently bound to 
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the carbohydrate matrix, most likely as a silanolate. The bridge between the 
Silicon atom and carbohydrate polymer chain would consist of a Si-O-C group. 
Several studies have shown the importance of Silicon in growth and bone 
formation. For diatoms, Silicon was required for cell proliferation, and as a 
regulator of DNA replication. Cyclic AMP level was increased by addition of 
Silicon to a Silicon-starved diatom culture (Simpson TL & Volcani BE, 1981 ). 
Silicon also stimulates DNA synthesis and proliferation in mammalian bone and 
fibroblast cells (Keating et al. 1992). In 1992, Keeting et al. showed that Silicon 
t_reatment increased the proliferation rate in human osteoblast culture. In other 
studies, Silicon deficiency caused an alteration of bone growth to defective 
connective tissue formation and reduced bone matrix synthesis; moreover, 
Silicon supplementation stimulated cartilage and bone formation (Carlisle EM, 
1980). 
The accumulation of Silicon and Calcium in the osteoblast occurs before any 
evidence of extracellular ossification. Bone formation depends on the activity of 
osteoblasts, which synthesize the organic matrix and modulate the calcification 
process. In addition to controlling matrix synthesis they also regulate exchange 
of ions between extracellular fluids and mineralizing bone. In this cytoplasmic 
localization pattern of molecules, Silicon and Calcium show localized patterns, 
whereas Magnesium and Phosphorus do not show localization (Carlisle EM, 
1975 & 1981 ). 
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In addition, recent studies showed the effects of Silicon on osteogenic activity. 
Silicon supplemented culture medium made a contribution to up-graded DNA 
synthesis, alkaline phosphatase activity and osteocalcin synthesis in a dose-
dependent manner (Keeting et al. 1992; Matsuoka H, 1999). 
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Impact of MTA in the field of Endodontics 
Root canals can harbour numerous species of bacteria which can migrate into 
periradicular tissues and cause the development of periradicular lesions. 
Removal of the irritants and inflammed pulpal tissue within the root canal system 
in three dimensions is the main goal of nonsurgical root canal therapy. Since 
root canal systems are complex, it can be challenging to completely clean these 
systems using present techniques and instruments. 
The preferred treatment of failing endodontic cases is non-surgical retreatment. 
Usually retreatment results in successful outcomes. However, because of the 
complexity of root canal systems, inadequate instrumentation and presence of 
physical barriers, it may be difficult to achieve ideal goals with a non-surgical 
approach. Therefore surgical endodontic therapy becomes the first alternative. 
The procedure involves exposing the involved apex, resecting the root-end, and 
inserting a root-end filling material. The purpose of placing a root-end filling 
material during periradicular surgery is to create a seal to prevent leakage of root 
canal contents into the periradicular tissues (Tang H et al., 2002). 
Endodontically treated teeth that require surgical treatment often have chronic 
apical periodontitis associated with them . These low-grade persistent lesions are 
formed in response to the presence of bacteria and their byproducts, or foreign 
materials such as gutta-percha, amalgam, and endodontic sealers that may 
cause irritation to the periradicular tissue. The soft tissue lesion continues to 
expand as long as the irritants keep emanating from the root canal system. The 
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inflammatory process continues and the cytokines released from the 
inflammatory mediators activate osteoclasts resulting in bone resorption and the 
creation of a bony defect around the apical portion of the root. 
During surgical treatment of an endodontically treated tooth, a sulcular full 
thickness flap or a mucoginigival flap design is used to gain access to the 
periradicular area. To expose the root end, the buccal cortical plate must be 
removed. A round window is made in the cortical plate; this is known as an 
osteotomy. An ideal osteotomy should be 4-5 mm to allow for manipulation of 
micro-instruments. As the root end is exposed, the granulomatous soft tissue is 
curettaged prior to resecting the root tip. Once the periradicular area is free of 
granulation tissue, and the root tip can be clearly identified, 3 mm of root tip is 
resected perpendicular to the long axis of the root. The apical preparation is 
made by using ultrasonics to a depth of 3 mm. The preparation is dried and an 
ideal root-end filling material is used to seal the apical region (Kim S, 2000). 
Recent research in endodontics has focused on the development and the ability 
of various techniques and filling materials to enhance optimal tissue healing. 
Root-end filling materials are designed to stimulate hard and soft tissue repair in 
the periradicular tissues and have been followed upon. To create a hermetic 
seal that prevents the egress of the contents within root canals is the main goal 
of placing a root end filling material. 
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The ideal root-end filling material according to Gartner and Dorn (1992) should 
be easy to use, dimensionally stable, biocompatible, provide a good seal to the 
root canal in three dimensions, be nonabsorbable, insensitive to moisture, 
nontoxic, and radiopaque. The material should also provide an environment 
condusive to healing and possess the ability to induce osteogenesis and 
cementogenesis. Numerous materials have been suggested as root-end filling 
materials, including: gutta-percha, zinc-oxide-eugenol, IRM, Super EBA, Gavit, 
composite resin, and MTA (Torabinejad Met al., 1995). 
Amalgam has long been used as the standard for root end filling material. Its 
popularity derives from its use for more than a century. It has been proven to be 
well tolerated by oral tissues. Its potential disadvantages are: initial marginal 
leakage, corrosion, tin and mercury contamination of periapical tissues, moisture 
sensitivity of some alloys, the need for a retentive undercut preparation, staining 
of hard and soft tissues and technique sensitivity (Gartner & Dorn 1992; Adamo 
HL et al., 1999). However numerous studies have shown that amalgam cannot 
prevent leakage (Alhadainy HA et al., 1993; Kos WL et al., 1982.). Clinical and 
radiograph examinations of cases after the use of amalgam as a root-end filling 
material in patients could be caused by its inability to prevent bacterial leakage. 
An alternative to amalgam is the Silicon-reinforced zinc oxide eugenol-based 
cement containing ethoxybenzoic acid, Super-EBA. Advantages are as follows: 
it adheres to dentinal walls, the reinforcement with silicon dioxide diminishes the 
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problem of absorbability found with ZOE alone, it has been associated with the 
formation of collagen fibers growing into and over its surface. Disadvantages are 
as follows: moisture sensitivity, eugenol irritation of periapical tissues, partial 
solubility in oral fluids, technique sensitivity, and radiotranslucency (Torabinejad 
M, et al., 1992). 
At present there are many studies on the the comparison of root-filling materials 
that are commonly used. MTA has been shown to have good sealing 
charateristics, an alkaline pH, stimulates dentin bridge formation, and adaptation. 
Biologic evaluations using cell cultures (Koh ET, et al., 1997, 1998), rat 
subcutaneous implants (Holland R, et al., 1999) and application to the teeth of 
dogs and monkeys (Torabinejad M, et al., 1995, 1997) have shown good results, 
concluding that MTA has the properties to seal root canals three dimensionally. 
In order for proper healing after retrograde endodontic treatment, the repair 
process allows for the replacement of new, healthy bone and the formation of a 
continuous thin layer of new cementum covering the exposed dentin surface and 
root-end filling material (Torabinejad M, et al., 1995, 1997). Studies have shown 
that MTA is a biocompatible substrate to which formative cells can attach and 
produce new soft or hard tissue (Torabinejad M, et al., 1995) and grow intimately 
with this cement (Koh ET, et al. , 1998; Zhu Q et al., 2000). MTA seems to 
stimulate the repair of periradicular tissues, but the nature of newly formed tissue 
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and the mechanism of mineralization and hard tissue formation that MT A induces 
needs to be investigated further. 
MTA 
Mineral Trioxide Aggregate is a relatively new material with numerous clinical 
applications in endodontics. It has been reported to stimulate the healing of the 
periradicular tissues to almost normal pre-operative status when used as a root-
end filling material. MTA has been used as an apexification material because it 
permits an adequate seal of the canal and prevents bacterial leakage 
(Shabahang S, et al. 1999). When it is used for apexification, it is placed as an 
apical barrier and allowed to set for 3-4 hours, before obturation. MTA was 
developed to seal communications between the tooth and the external surface 
(Lee SJ, et al. 1993). 
The main constituents of this material are: tricalcium silicate (Ca Si0 4), bismuth 
oxide (Bb03), dicalcium silicate (2Ca0Si0 2), calcium sulphate (CaS0 4), 
tricalcium aluminate (3Ca0Ab03), tetra calcium aluminoferrite (4Ca0Ab0 3Fe0 3) 
and an amorphous structure consisting of 33% calcium, 49% phosphate, 2% 
carbon, 3% chloride, 6% silica (Torabinejad et al. , 1995). 
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Indications for the use of MTA 
Current uses of MTA include: root-end filling material in apexification and 
periradicular surgery, apical plug during apexogenesis, repair of root perforations 
during root canal therapy as a consequence of iatrogenic damage or internal 
resorption, and pulp capping material. 
Sealing ability of MTA 
The ability of repair materials to seal furcation perforations in vitro has been 
tested using dyes, bacteria, radioisotopes, and fluid filtration. Previous studies 
have shown that MTA provided a better seal compared with amalgam, Super-
EBA or IRM (Torabinejad M, et al., 1995). In an in vivo study in dogs, when root-
end fillings of amalgam and MTA were exposed to the oral flora, MTA samples 
showed less inflammation and more cementum formation compared with the 
amalgam samples (Torabinejad M, et al., 1995). This study confirms the results 
of the in vivo and in vitro studies showing that MTA prevents bacterial leakage 
better than amalgam when used as a root-end filling material. 
In vitro studies have demonstrated that the antibacterial effects of MTA are 
comparable to calcium hydroxide but MTA is more effective in preventing 
bacterial microleakage. To further examine the sealing ability of MTA, an 
endotoxin , lipopolysaccharide, was used. It was reported that MTA provided the 
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most effective seal against endotoxin leakage (Tang HM, et al., 2002). MTA also 
demonstrated to seal against Prevotella nigrescens when teeth were filled 3 mm 
apically with MTA at the root end. MTA prevented the leakage of this bacteria 
(Scheerer SQ, et al. ,2001 ). A comparative study of bacteria leakage with 
Serrata marcescens was conducted to evaluate bacterial leakage through 3 mm 
of the filling materials IRM, amalgam, Super-EBA and MTA. MTA exhibited 
leakage at 49 days after exposure to bacteria, which was later than the other _ 
materials (Fisher EJ et al., 1998). 
Cementum regeneration and MTA 
Healing of the surrounding bone is an important consideration regarding 
treatment. The ultimate sign of success is regeneration of the periodontal 
attachment apparatus including cementum overlying the resected root-end 
surface, periodontal ligament, and alveolar bone. The formation of cementum 
against MTA may be because of its superior marginal adaptation. In addition, 
MTA has the unique ability to induce cementum formation directly adjacent to its 
surface (Torabinejad M, et al., 1995; 1997). The reason for the cementum 
formation against MTA may be because of its superior marginal seal 
(Torabinejad M, et al. 1993; 1994). Apaydin et al. compared the healing and 
extent of cementum deposition on resected set MTA with fresh MTA as a root-
end filling material in dogs. The frequency of cementum formation with 
retrograde MTA was higher when compared with that of resected MT A. When 
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comparing the amount of cementum formation in the two groups they found no 
significant difference between the two groups. Based on their results, it appears 
that fresh MTA is more inductive than resected set MTA. However, the presence 
of resected set MTA adjacent to periradicular tissues did not prevent 
regeneration of these tissues in a majority of cases. 
Pulpal healing with MTA 
Pitt Ford et al. (1996) have documented that MTA placed in mechanically 
exposed pulps of monkeys stimulated pulp healing with dentinal bridge formation 
and minimal inflammatory reactions. The early pulpal cell response to MTA and 
the mechanism by which extracellular matrix is deposited after its application at 
pulp capping situations needs to be determined. Experiments have 
demonstrated that pulp capping with MTA induces cytological and functional 
changes in pulpal cells resulting in the formation of fibro dentin and reparative 
dentin at the surface of the mechanically exposed dental pulp. These findings 
agree with observations made previously in cultures with osteoblasts grown on 
MTA (Koh ET eta/., 1997; Mitchell Peta/., 1999). MTA offers a biologically 
active substrate for pulpal cells able to regulate dentinogenic events. Pulp cell 
responses were studied here in short-term healing intervals to evaluate whether 
or not MTA induces directly reparative dentinogenesis or if the intermediate 
formation of osteodentin I fibrodentin precedes any dentinogenic event. The 
initial effect of MTA on the surface of mechanically exposed pulp is the formation 
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of a superficial layer of crystalline structures onto the pulpal surface of the 
capping material. 
The formation of an appropriate pulp environment due to the alkaline properties 
of MTA favoring expression of the dentinogenic potential of pulpal cells as has 
been suggested for calcium hydroxide treated pulps (Torneck et al., 1983; Cvek 
et al., 1987). The regulatory effect of MTA in production of osteocalcin or 
alkaline phosphatase or cytokine production might be further related to the 
stimulation of dentinogenic activity in the dental pulp treated with MT A. MTA is 
an effective pulp-capping material that is able to stimulate hard tissue bridge 
formation during early in the wound healing process. The pulpal defense 
mechanism by which the primitive matrix (fibrodentin) triggers expression of the 
odontoblastic potential of pulpal cells seems to be related to the dentinogenic 
activity of MTA (Tziafas D et al., 2002). 
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Perforation repairs with MTA 
Perforation within the root may occur during the root canal procedure or can be 
due to pathologic or iatrogenic communication between the root canal and the 
attachment apparatus. It is a common cause of root canal failures and the 
prognosis is dependent on several factors. The size, location and time are 
important determining factors on a successful outcome of treatment. The main 
concern is the prevention of bacterial infection at the site of the perforation. 
Therefore a seal on the location of the perforation is of utmost importance. 
The healing properties of MTA have been compared to amalgam when used 
either as a root-end filling material or in the repair of experimentally induced 
furcal perforations (Torabinejad M et al., 1995). It has been shown that MTA 
produces significantly less inflammation and more fibrous capsule formation 
when compared to amalgam. In experimental induced perforations in dogs the 
periodontal tissue reaction to amalgam and MTA used as repair materials were 
used immediately after perforation or after salivary contamination (Pitt Ford TR et 
al., 1996). Teeth that were repaired immediately with MTA lacked inflammation 
and cementum was formed on five out of six teeth. In the specimens where the 
repair was delayed, three of seven teeth treated with MTA had no inflammation. 
In an in vitro study of furcal perforation repair, MTA was compared with 
Vitrebond, a resin modified glass ionomer cement. It was found that perforations 
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repaired with MTA leaked significantly less that those repaired with Vitrebond 
(Daoudi MF et al. 2002). 
Periradicular healing with MTA 
Regeneration has been defined as the replacement of tissue components in their 
appropriate location, amounts and relationship to each other. This implies 
reformation of the bone in the surgical site adjacent to a fully reconstituted 
periodontal ligament which is attached to newly formed cementum over the 
resected root end and the root-ending filling material. MTA can supply almost 
complete regeneration of the periradicular periodontium when used as a root-end 
filling material in periradicular surgery (Regan RG, et al., 2002). The occurrence 
of this type of tissue regeneration has not been demonstrated when amalgam, 
gutta-percha, glass ionomers, intermediate restorative material (I RM) or Super 
EBA have been used as root-end filling materials, as none of the aforementioned 
materials have exhibited cementa! regrowth over their surfaces. Inherent in the 
tissue response to the root end filling material is the potential for the material or 
its constituents to influence the extracellular matrix (ECM) (Craig RG, et 
al., 1997). This influence will determine specific cellular induction and matrix 
formation characteristics of the phenotype expression of osteoblasts, fibroblasts, 
and cementoblasts. Recent histological studies have demonstrated the strong 
possibility of cementa! regeneration over the root endodontic filling when either 
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MTA was used. Neither study has specifically characterized the immunological 
nature of this covering material. 
Periradicular tissue response to MTA was observed with monkeys. After root 
canals were prepared and filled , surgical procedures were performed and MTA 
was used as a root-end filling material. After five months the periradicular tissue 
response was studied histologically. The result showed that there was no 
periradicular inflammation adjacent to the root ends filled with MTA and that a 
complete layer of cementum was observed over root ends with MT A 
(Torabinejad M et al., 1997). 
Immune response in the presence of MTA 
Immune response to MTA exposure has also been evaluated. Histological 
evaluation of the tissues around implants of MTA and Super-EBA were 
conducted in guinea pigs. The evaluation showed that the tissues surrounding 
the implants revealed a milder tissue reaction to MTA compared to Super-EBA. 
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MT A and Osteogenesis 
MTA has been observed through studies with cultured human osteosarcoma 
cells in the presence of MTA. Successful growth cell cultures have been found, 
demonstrating that MTA offers a biologically active substrate for cell attachment, 
while increasing levels of alkaline phosphatase, osteocalcin, and cytokine (Koh 
ET et al., 1997). In 1997 Koh et al. studied the cytomorphology of osteoblasts 
and cytokine production in the presence of MTA . They confirmed that MTA 
offers a biologically active substrate for bone cells and stimulates interleukin 
production. In response to the material, cell growth was favorable. The 
expression of IL-6 and IL-8 suggests that MTA may promote healing through the 
simulation of bone metabolism. The behavior of MG-63 osteosarcoma cells was 
examined with respect to cytokine and osteocalcin production and ALP activity. 
Zhu et al. reported that osteoblasts have a favorable response to MTA by the 
demonstration of cell adhesion and spreading onto the MTA, as compared to 
IRM and amalgam (Zhu Q et al., 2000). Further studies have confirmed the 
biocompatibility of MTA in cultures of osteoblasts (Koh ET et al., 1997; Zhu Q et 
al., 2000.; Mitchell P et al., 1999). 
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OBJECTIVES OF THIS STUDY 
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Objectives of the Study 
The objective of this study was to evaluate the behavior of normal human 
osteoblast cells in the presence of Silicon-modified mineral trioxide aggregate 
when compared to the original mineral trioxide aggregate. Based on previous 
findings in literature, we hypothesize that the osteogenic behavior of human 
osteoblast cells will increase with an increase of Silicon in mineral trioxide 
aggregate. 
The experiments were designed to achieve the following objectives: 
1. The isolation and growth of osteoblast-like cells . 
2. The characterization of human osteoblast cell culture. 
3. Examination of the effects of MTA and modified-MT A on media pH. 
4. Examination of the effects of MTA and modified MTA on cell attachment 
efficiency and proliferation rate. 
5. Examination of the effects of MTA and modified-MT A on alkaline 
phosphatase activity. 
6. Examination of the effects of MTA and modified-MTA on osteocalcin 
expression. 
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I MATERIALS AND METHODS 
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1. Materials 
Material Manufacturer Lot Location Formula 
Number 
1,25 Sigma C27H4403 St. Louis, C27H44O3 
Dihydroxycholecalciferol MO 
(1 a, 25-Dyhydroxyvitamin 
03; calciferol) 
Alkaline Phosphatase Sigma 014K6010 St. Louis, C5H4NNa205P· 
Substrate MO 6H20 (FW 371.14) 
Alkaline Buffer Solution, Sigma 113K6053 St. Louis, NIA 
1.5M (ALP Reaction) 2- MO 
amino-2-methylpropanol 
Charcoal treated FBS Cocalico CBX 1730 Reamstown, NIA 
Biological PA 
Crystal Violet (N- Sigma St. Louis, C2sH30CIN3 
hexamethylpararosaniline) MO (FW 408.0) 
Dulbecco 1s Modified Life 1191232 Rockville, NIA 
Eagle Medium (DMEM) Technologies MD 
Ecoscint H National 069718 Atlanta,GA NIA 
Diagnostics 
Ethyl alcohol USP Paper Alcohol 98L09QA Shelbyville, NIA 
Absolute-200 Proof and Chemical KY 
Co. 
F-12 Nutrient Medium Life 1188646 Rockville, NIA 
(Ham) Technologies MD 
Fetal Bovine Serum (FBS) Life Rockville, NIA 
Technologies MD 
Formalin solution 10% Sigma 018H3278 St. Louis, CH2O 
Diagnostics MO 
Fungizone Amphotericin B Life 3083711 Rockville, NIA 
Technologies MD 
Human Osteocalcin Kit Nichols 401507R San Juan NIA 
Institute Capistrano, 
Diagnostics CA 
L-Ascorbic acid Sigma 115H02865 St. Louis, C5HaO6 
MO 
Menadione (Vitamin K3;2- Sigma 18H0300 St. Louis, C11HaO2 
methyl-1-4- MO (FW 172.2) 
naphoquinone) 
Mineral Trioxide Dentsply 03081235 Tulsa,OK NIA 
Aaaregate (MT A) 
Penicillin-Streptomycin Life 1140683 Rockville, NIA 
Technologies MD 
43 
Potassium Chloride Fisher 942637 Fair Lawn, KCI 
NJ (MW 74.56) 
Potassium Phosphate, Fisher 004920 Fair Lawn, KH2PO4 
monobasic NJ (MW 136.09) 
Silicon Dioxide US Silica 15033100 Berkeley SiO2 
Springs, WV 
Sodium Chloride Fisher Fair Lawn, NaCl 
NJ (MW 58.44) 
Sodium Hydroxide Sigma 06724CB St. Louis, NaOH 
MO (MW 40) 
Sodium Phosphate, Fisher 975648 Fair Lawn, Na2HPO4 
dibasic, Anhydrous Biotech NJ (MW 141.56) 
Triton X-100 Sigma 34H260015 St. Louis, N/A 
MO 
Trypsin 0.25% Life 1194331 Rockville, N/A 
Technologies MD 
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2. Equipment 
Item Manufacturer Model No. Location Description 
Gram-ATIC E. Mettler 1-910 Switzerland/ Balance 
Balance Zurich/Fisher Height, NJ 
Scientific 
Metler PM 480 Delta RanQe® PM 480 Heights,NJ Balance 
Centric TM Fisher 225 Heights, NJ Centrifuge 
CentrifuQe Scientific 
EASY Pure RF Barnstead D7031 Dubuque, IA Deionizer 
Compact 
Ultrapure 
Water System 
Spectral Liquid Wallac Inc. All 1219 Gaithersburg, Gamma Counter 
Scintillation MD 
Counters 
PRECISION Precision 5EM Winchester, Incubator 
Economy Scientific VA 
Incubator 
Water- Forma 3158 Marjetta, OH Incubator 
Jacketed Scientific Inc. 
Incubator 
DAS Mikroskop Leitz DMIL 090- Wetzlar, Microscope 
131.002 Germany 
Accumet Metro Fisher 01375 USA PH meter 
(Acco-pHast™ Scientific (69490) 
Combination 
Electrodes) 
Gyrotory ® New G2 Edison, NJ Shaker 
Shaker Brunswick 
Scientific Co. 
Inc. 
Spectronic ® Spectronic 400114 Rochester, Spectrophotmeter 
20 Genesys Instruments NY 
BD Falcon BD 353134 Bedford, MA Tissue Culture 
75cm2 Flask Biosciences treated 
polystyrene, 
sterile, non-
pyroQenic flask 
Costar 24 Well Corning Inc. 3524 Conring, NY Tissue culture 
Cell Culture treated 
Cluster polystyrene 
sterile, non-
pyroQenic 
Touch Mixer Fisher 231 Heights,NJ Vibrator 
Scientific 
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BO Falcon BO 353107 Bedford, MA Tissue culture 
12.5cm2 flask Biosciences treated 
polystyrene 
sterile, non-
pyrogenic 
Redi-Tip™, Fisher 211978J Fair Lawn, NJ Sterilized pipette 
101-1000ul Scientific tips 
Redi-Tip™, 1- Fisher 02681457 Fair Lawn, NJ Steriliezed 
200ul Scientific Pipette Tips 
Fisherbrand ® Fisher 1367811D Fair Lawn, NJ pipette 
Disposable Scientific 
serological 
pipettes, 5 ml 
Fisherbrand ® Fisher 1367811E Fair Lawn, NJ Pipette 
Disposable Scientific 
serological 
pipettes, 1 O 
ml 
Fisherbrand ® Fisher 1367811 Fair Lawn, NJ pipette 
Disposable Scientific 
serological 
pipettes, 25 ml 
Fisherbrand ® Fisher 055392 Fair Lawn,NJ Centrifuge tube 
Disposable Scientific 
Centrifuge 
Tubes, 15 ml 
Fisherbrand ® Fisher 055396 Fair Lawn, NJ Centrifuge tube 
Disposable Scientific 
Centrifuge 
Tube, 50 ml 
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3. Methods Section 
Harvesting Human Osteoblast Cells 
Human alveolar bone chips were obtained from healthy 18-25 year old patients 
who came to the Boston University School of Dental Medicine Oral Surgery Clinic 
for routine extraction of impacted third molars. Informed consent was obtained 
for each case in accordance with the policies of the university. The bone chips 
that were used in this study were considered waster material since there was no 
extra procedure in order for the specimens to be obtained. Each patient was in 
good health with no systemic or metabolic diseases. 
After the bone chips were collected, the specimens were placed in 5 ml of cold 
PBS solution supplemented with antibiotic in 15 ml centrifuge tubes and 
transported to the lab area. In a biological hood, the bone chips were washed 
with PBS solution to remove blood residues and soft tissue was removed with a 
sharp #15 blade to thoroughly clean the bone chips. After the bone chips were 
completely cleaned showing a white appearance, a rongeur or #15 blade was 
used to mince the bone chips into 2-3 mm explants. Three to four explants were 
placed in a 12.5 cm2 polystyrene tissue culture flask with 2 ml of culture medium. 
It was critical to plant the explants within a two hour time span from the time the 
bone was collected from oral surgery to the placement of the bone chips into the 
culture flask. The culture medium consisted of 40% Dulbecco•s Modified Eagle 
Medium (DMEM), 40% F-12 nutrient mixture (Ham) with L-glutamine, 10% Fetal 
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Bovine Serum (FBS), Penicillin-Streptomycin (5000 U/ml) and 10% Fungizone. 
The tissue flask cultures were maintained at 37°C, 5% CO2 under saturated 
humidity. The culture medium was changed ever 24 hours for seven days from 
the time the bone chips were initially placed into the 12.5 cm2 culture flask. After 
the seventh day, the culture medium was changed every three days. Osteoblast-
like cells started to grow after 7-10 days of culture, growing from the explant and 
attaching to the plastic surface of the flask. 80% confluency in the 12.5 cm2 
culture flask was reached after 3-4 weeks, whereupon the cells were transferred 
to a 75 cm2 polystyrene flask. 
To transfer the cells, the expants were removed from the 12.5 cm2 flask and 
discarded. Culture medium was removed using a Pasteur pipette and 3 ml of 
0.25% trypsin was added in to the flask for 10 seconds . After 10 seconds, the 
trypsin was removed, and another 3 ml of 0.25% trypsin was added into the 
flask. The flask was incubated in 37°C with 5% CO2 and 100% humidity for 7-1 O 
minutes. Cells were periodically checked to see if they were detaching, floating 
and rounded up. While cells were incubating, 7 ml of culture medium was 
prepared in a 15 ml centrifuge tube, and acted as a neutralizing solution. Once 
the cells were in suspension, the suspension in the flask was added to the 
centrifuge tube containing culture medium which brought the total volume within 
the centrifuge tube to 10 ml. The tube was then centrifuged at 1500 rpm for 7 
minutes. 
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The supernatant was poured off into the waste container and the cell pellet was 
resuspended with 10 ml of culture medium. The cell suspension was then 
transferred to a 75 cm2 polystyrene tissue culture flask that contained 10 ml of 
fresh culture medium, bringing the total volume to 20 ml. The 75 cm2 flask was 
incubated at 37°C with 5% CO2 and 100% humidity. The culture medium was 
changed after the first 24 hours, then every three days there after until cells 
reached confluency, which was in about 10-12 days. 
Modified-MT A was mixed 48 hours prior to the start of the experiments. SiO2 
equal to 15% of the total weight of the MTA powder was added to make a 
powder mixture. The modified-MT A was mixed overnight using a tumbler mixing 
device on gentle cycle. 
24 hours prior to the start of the experiments, both MTA and modified-MTA 
powder were mixed with saline according to the MT A manufacturer's instructions 
under septic conditions. Discs of the two different materials were condensed into 
the wells of 24-well cell culture plates. The discs measured 15.5 mm in diameter 
with 1 .5 mm thickness . The cell culture plates containing the discs were allowed 
to set in the incubator, at 37°C, 5% CO2 and 100% humidity. 
Osteoblast-like cells that were cultured in the 75 cm2 flask were used to screen 
for osteoblast phenotype. Once the cells within the 75 cm2 flask reached 100% 
confluency, the culture medium was removed and the cells were rinsed with 10 
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ml of 0.25% trypsin solution for 10 seconds. The trypsin was discarded and fresh 
15 ml of 0.25% trypsin solution was added into the flask and incubated for 7-10 
minutes at 37°C, 5% CO2 and 100% humidity. While cells were incubating, two 
15 ml centrifuge tubes were prepared, each containing 7.5 ml of culture medium. 
Cells were periodically checked to see if they were detaching, floating and 
rounded up. Once cells were fully detached, 7.5 ml of cell suspension was 
transferred into each 15 ml tube to reach a total volume of 15 ml within the tube. 
The tube was centrifuged at 1500 rpm for 7 minutes. The supernatant was 
poured off discarded as waste. The cell pellet was resuspended initially with 10 
ml of culture medium in each 15 ml tube , and then the resuspended cells were 
combined together into a 50 ml centrifuge tube . Cells were counted using a 
hemocytometer and microscope for standardization of culture condition and 
proper quantitative experiments. A 20 µI volume of cell suspension at the end of 
the second passage was transferred immediately to the edge of the 
hemocytometer chamber. The cell suspension was drawn under the glass 
coverslip by capillary action as it ran out of the pipette. The 10 X objective of the 
microscope was selected and focused on the grid lines in the hemocytometer 
chamber. The cells in the largest area bounded by three parallel lines were 
counted. Cells on the top and left-hand lines were counted, while those on the 
bottom and right hand lines were not. Cell concentrations were calculated by 
number of cells counted I volume counted in ml (Freshney RI, 1994). 
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Cells were seeded at 1 .5 x 105 cells /ml into the 24-well plates and divided into 
MTA, modified-MTA, and control group (cells were grown directly on the plastic 
surface of the well). These cells were cultured for periods of 16 hours, 12 and 20 
days to observe various degrees of osteoblast phenotypic behavior. The times 
chosen for these experiments were based on temporal events of osteogenesis. 
Osteoblastic cell proliferation usually peaks around 12 to 18 days. In our 
experiments, we examined cell attachment efficiency, cell proliferation rate at 12 
and 20 days of culture, culture medium pH changes , and the levels of alkaline 
phosphatase and osteocalcin released at 12 and 20 days of culture. 
Measurement of Cell Attachment Efficiency 
Cells grown on the three surfaces, MT A, modified-MT A, and control groups were 
fixed and stained with crystal violet dye using the following procedure. The 
culture media was removed ; cells were rinsed twice with PBS and then fixed with 
1 ml of 10% neutral buffered formalin for 30 minutes at room temperature. The 
formalin was removed and the cells were rinsed twice with deionized water. After 
all the cells were rinsed, 1 ml of 0.2% solution of crystal violet dye was added to 
each well and was allowed to remain there for 30 minutes at room temperature to 
stain the cells. The unbound stain was removed with extensive rinsing with 
deionized water until the rinsate was clear. To remove the bound stain, 500 µI of 
1 % Triton X-100 was added to each well and the plates were placed on a shaker 
at 150 rpm at room temperature for 5 minutes. This solution was then removed 
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and placed in a cuvet and the process was repeated once more to bring the total 
volume in the cuvet to 1 ml. The optical density was measured at 590 nm in a 
spectrophotometer. All data was collected and the numbers of the attached cells 
were calculated using a conversion factor relating the optical density of the 
bound crystal violet dye to the number of cells. This was conducted during 16 
hours of attachment, 12 and 20 days of attachment and proliferation. 
Conversion Factor for Crystal Violet Dye 
In order to interpret the number of cells that were attached using the crystal violet 
dye technique, a conversion factor was needed. Using repeated1 :2 dilutions we 
were able to dilute the crystal violet solution down to 0.015 µg/ml. The optical 
densities were measured after each dilution in a spectrophotometer at 590 nm. 
From the collected data, a standard curve was generated and the slope of the 
curve was calculated. In order to correlate the dye to the number of cells, cells 
were seeded into wells starting with 4.0 x 105 cells and diluted in 1 :2 dilutions. 
Cells were allowed to attach for 16 hours and were fixed and stained using the 
crystal violet dye method giving an optical density measurement. Since this was 
done in duplicate, one line of cells was used for crystal violet and the other line 
was used for cell counting using the hemocytometer method. Thus, a standard 
curve could be generated in order to find the slope to use as a conversion factor 
in order to convert optical density to cell numbers for subsequent crystal violet 
experiments. 
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Screening of Osteoblast Phenotypic markers 
Assays for 1,25-dihydroxyvitamin 0 3 stimulated alkaline phosphatase activity 
(Kostenuik PJ et al., 1997; Rattner A et al., 1997) and osteocalcin release 
(Keeting PE, 1992) were performed to detect the proteins that are characteristic 
of human osteoblast phenotype. 
Assays for alkaline phosphatase 
Spectrophotometric measurements at 405 nm of the release of p-nitrophenol 
phosphate (pip) were used to detect alkaline phosphatase activity. Cells were 
cultured in 24-well plates with culture medium consisting of DMEM, F-12, FBS 
and antibiotics for 1 O and 18 days at 37°C, 5%CO2 at 100% humidity. At the 
10th and 18th day, two days before the actual day of experiments, differentiation 
medium was added to the cells. Differentiation medium consisted of DMEM/F-12 
1 :1 with 0.2% charcoal stripped FBS (Olea N et al., 1996), 100 µm/ml of ascorbic 
acid, 1 o·8 Menadione and 1 nM 1,25-dihydroxyvitamin 0 3 . The cells that were 
cultured to 12 and 20 days were used to test alkaline phosphatase expression. 
The medium was collected at 12 and 20 days was used to test for osteocalcin 
expression. 
53 
Measurement of alkaline phosphatase activity 
In order to measure the amount of alkaline phosphatase released, a p-
nitrophenyl phosphate di-sodium hexahydrate phosphatase substrate combined 
with an alkaline 1 .5M 2-amino-2-methylpropanol buffer was used from Sigma 
Diagnostics was used. Cells were washed two times with PBS then fixed with 
10% neutral buffered formalin for 30 minutes at room temperature. After the cells 
were fixed, the cells were washed twice with PBS. Then 500 µI of phosphatase 
substrate and 500 µI of alkaline buffer were added to the cells in each well and 
allowed to incubate at 37°C, 5% CO2 at 100% humidity for 30 minutes. After 
incubation, 0.05 N (500 µL) NaOH was added to stop the alkaline phosphatase 
reaction. The solution was removed from each well, placed into a cuvet and read 
at 405 nm in a spectrophotometer. 
Measurement of Osteocalcin Activity 
A human osteocalcin kit (Nichols Institute Diagnostics) was used. This was a 
two-site immunoradiometric assay (IRMA) to measure intact osteocalcin. This 
involved two different monoclonal antibodies to human osteocalcin. One 
antibody specific to the 7-19 region of the osteocalcin peptide was coupled to 
biotin and used to capture osteocalcin molecules. The second antibody 
recognized the 37-49 region of the peptide and was radiolabelled for detection. 
The extracted culture medium (50 µm) and known osteocalcin standards, which 
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were provided in the kit, were mixed with 125I-labelled antibody, biotinylated 
antibody, and an avidin coated plastic bead, according to manufacturer's 
instructions. The osteocalcin contained in the sample was "sandwiched" 
between the biotinylated antibody and the radiolabeled antibody, and the 
"sandwich" complex was bound to the plastic coated bead by the avidin-biotin 
molecules. There the complex attached to the bead was: 
Avidin Coated Bead--Biotin Anti-Osteocalcin--Osteocalcin-- 125I Anti-Osteocalcin 
(sample) 
These mixtures were incubated for 3 hours at 18-25°C on a 200 rpm shaker. The 
beads were rinsed three times with the washing solution provided in the kit to 
remove the un-bound labeled antibody. The rinsed and aspired beads were 
placed in a scintillation vial and 5 ml of scintillation cocktail was added. The 
radioactivity bound to the bead was measured. A gamma counter (Spectral 
Liquid Scintillation Counters) was used to read counts per minute (CPM) of 1251. 
The counting was done once for 5 minutes. The radioactivity complex bound to 
the bead was directly proportional to the amount of osteocalcin in the sample. 
The true values of the CPM were corrected by subtracting the CPM of a blank 
background standard. The normalized values were compared with the standard 
curve of the osteocalcin (0-435 ng) that was performed using a serial amount of 
osteocalcin standard reagent provided in the kit. The results were expressed as 
the amount of osteocalcin in ng/104 cells. 
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RESULTS 
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1. pH changes in the culture medium 
The pH of the culture medium in the control, MTA, and modified-MT A groups was 
measured on day 1, and for every three days of culture thereafter until day 20. 
pH was measured by using an Accumet Metro pH meter with the Accu-pHast 
combination electrode when the culture medium was changed. The mean pH 
values of the cells cultured with MTA, modified-MTA, and control (cells cultured 
on the plastic well) were recorded for 14 cell lines. Comparing the three groups 
reveals a similar trend in that the pH of the culture medium decreased overall 
from day 1 to day 18, and slightly increased at the end of day 20. 
pH Day 1 Day3 Day6 Day9 Day 12 Day 15 Day 18 Day20 
MTA 8.14 ± 8.23 ± 7.96 ± 7.89 ± 7.85 ± 7.57 ± 7.69 ± 8.39 ± 
0.26 0.21 0.17 0.18 0.22 0.23 0.16 0.27 
MTA-Si 8.07 ± 8.24 ± 7.95 ± 7.85 ± 7.79 ± 7.60 ± 7.66 ± 8.12 ± 
0.30 0.30 0.14 0.16 0.12 0.22 0.16 0.11 
Control 7.99 ± 8.00 ± 7.90 ± 7.86 ± 7.76 ± 7.50 ± 7.42 ± 8.08 ± 
0.26 0.26 0.18 0.22 0.27 0.15 0.15 0.30 
Table 1. The mean pH values and standard deviations of cell culture medium 
from cells exposed to MTA, modified-MTA, and the control group (the absence of 
material). 
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Figure 1. The graph displays the pH values of culture medium exposed to MTA, 
modified-MTA, and the control group over 20 days in culture. 
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2. Cell Attachment Efficiency at 16 Hours 
Cell attachment efficiency was determined by measuring the optical density of 
the crystal violet dye that was bound to the nuclear contents of the cells that were 
attached to the cell culture plate in the control group, and to the MTA and 
modified-MTA discs in the experimental groups. At 16 hours of cell attachment 
there was no statistical significant difference between the cells attached to the 
control, MTA, or modified-MTA (p= 0.331). The attachment percentage was 
calculated by comparing the 16 hour attachment of cells to the average amount 
of cells that were seeded into each well (1.424 x 105 cells). 
Average number of cells Percent attachment 
attached ± standard deviation efficiency at 16 hours 
(x 104 cells) (compared to at 0 hours) 
MTA 10.70 ± 2.47 74.15% 
MTA-Si 10.62±2.16 74.58% 
Control 11.86 ± 1.05 83.29% 
ANOVA P= 0.331 
Table 2. The average number of cells attached at 16 hours and the percent 
efficiency of cells attached to MTA ,modified-MTA, and the control group. 
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Figure 2. Graph displays the attachment of cells to MTA, modified-MTA, 
and control group at 16 hours of culture. 
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3. 12 Day Total Cell Number and Proliferation Rate 
Cell proliferation rate was determined by normalizing cell numbers at 12 days of 
culture to observe the proliferation rate of cells from 16 hours to 12 days. 
Therefore, 16 hours of culture was considered the baseline . Cell numbers were 
determined by measuring the optical density of crystal violet dye extracted from 
cells fixed and attached to MTA, modified-MTA, and the control group. At 12 
days of culture, there was a statistical significant difference between the MTA, 
modified-MT A and control group compared using ANOVA. A t-test was used to 
determine if there was a significant difference between MTA and the control 
group. There was no significant difference between modified-MTA vs. control 
and MTA vs. modified-MT A. Measurement of the proliferation rate from 16 hours 
to 12 days of culture, indicated that there was a significant difference between 
MTA, modified-MT A, and the control group when compared using ANOV A. A 
significant difference was found with at-test comparison between MTA vs. 
control and modified-MT A vs. control. There was no significant difference 
between MTA and MTA-Si for the 12 day proliferation rate. 
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Number of cell attached at 12 days (x 104 cells) 
MTA MTA-Si Control 
68.47 ± 65.41 ± 22.81 36.49 ± 7.97 
17.25 
Table 3. The total number of cells attached to MTA, modified-MTA and 
control over 12 days of culture. 
Statistical Analysis P value 
ANOVA 0.0025 
MTA vs. Control 0.005 
MTA-Si vs. Control 0.08 
MT A vs. MT A-Si 0.33 
Table 4. Statistical analysis using ANOVA and t-test and the p values of 
the attachment of cells over 12 days of culture. 
Cell Attachment at 12 Days 
Test Groups 
DMTA 
■ MTA-Si 
□ Control 
Figure 3. Total number of cells attached to MTA, modified-MTA, and the 
control groups over 12 days of culture. 
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Proliferation Rate of Cells from 16 hours to 12 days 
MTA I MTA-Si I Control 
5.33 ± 1.35 I 5.19 ± 1.59 I 2.89 ± 0.82 
Table 5. Cell proliferation rate over 12 days of culture. 
Statistical Analysis P value 
ANOVA 0.0026 
MTA vs. Control 0.0045 
MTA-Si vs. Control 0.015 
MT A vs. MT A-Si 0.871 
Table 6. p values of the proliferation rate of cells over 12 days. 
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Figure 4. Cell proliferation rate at 12 days of culture. Values shown are 
means and standard deviations. 
63 
4. 20 Day Total cell Number and Proliferation 
Cell attachment and proliferation was measured at 20 days. Cell numbers were 
determined by measuring the optical density of crystal violet dye extracted from 
cells fixed and attached to MTA, modified-MTA, and the control group. When 
comparing the cells attached to MTA, modified-MT A, and control groups with an 
ANOVA analysis, there was a statistical significant difference. At-test was used 
to find a significant difference between MTA vs. control group and MTA-Si vs. 
control. There was no significant difference between MTA vs. modified-MT A. 
When comparing using ANOVA, the proliferation rate from 16 hours to 20 days of 
culture, there was significantly different between MTA, modified-MT A, and the 
control group when compared using ANOVA. A significant difference was found 
using a t-test comparison between MTA vs. control and modified-MTA vs. 
control. There was no significant difference between MTA and MTA-Si at the 20 
day proliferation rate. 
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Number of cell attached at 20 days (x 104 cells) 
MTA MTA-Si Control 
79.45 ± 67.88 ± 14.73 54 .59 ± 7.11 
14.24 
Table 7. The total number of cells attached to MTA, modified-MTA, and 
control groups over 20 days of culture. 
Statistical Analysis P value 
ANOVA 0.0056 
MT A vs. Control 0.0025 
MT A-Si vs. Control 0.165 
MT A vs. MT A-Si 0.23 
Table 8. p values of the attachment of cells over 20 days of culture . 
Cell Attachment at 20 Days 
Test Groups 
DMTA 
MTA-Si 
□ Control 
Figure 5. The total number of cells attached to MTA, modified-MTA, and 
control groups over 20 days of culture. 
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Proliferation Rate of Cells from 16 hours to 20 days 
MTA I MTA-Si Control 
7.20±1.11 I 6.s3 ± 1.20 4.69 ± 0.61 
Table 9. Cell proliferation rate over 20 days of culture. 
Statistical Analysis P value 
ANOVA 0.0007 
MTA vs. Control 0.0005 
MT A-Si vs. Control 0.046 
MT A vs. MT A-Si 0.368 
Table 10 . p values of the proliferation rate of cells over 20 days. 
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Figure 6 . Cell proliferation rate at 20 days of culture. Values shown are 
means and standard deviations. 
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5. Alkaline Phosphatase Activity at 12 days 
Alkaline phosphatase activity was determined by measuring the optical density of 
p-nitrophenol released from p-nitrophenol phosphate. At 12 days of culture there 
was a significant difference between the three groups: MTA, modified-MTA, and 
control group using ANOVA analysis. Under at-test comparison, there was a 
significant difference in amounts of ALP expressed when comparing MTA with 
the control and MTA-Si with the control. There was no statistical significant 
difference between MTA and MTA-Si. The control group produced the highest 
amount of p-nitrophenol overall when compared to the MTA and MTA-Si groups. 
Avera e concentration of -nitro heno in mM cells 
MT A MT A-Si ontrol 
3.26 ± 1.53 3.50 ± 1.85 9.35 ± 5.89 
Table 11. The average concentration of p-nitrophenol expressed over 12 
days of culture. 
Statistical Analysis P value 
ANOVA 9.26 X 10-7 
MTA vs. Control 0.004 
MT A-Si vs. Control 0.002 
MT A vs. MT A-Si 0.813 
Table 12. Statistical analysis of ALP over 12 days of culture. 
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Alkaline Phosphatase Activity at 12 Days 
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Figure 7. ALP activity at 12 days of culture. Values shown are means 
and standard deviations compared between the three groups. 
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6. Alkaline Phosphatase Activity at 20 days 
Alkaline phosphatase activity was observed and compared between the three 
. groups: MTA, MTA-Si, and control groups. At 20 days of culture there was a 
significant difference between the three groups using an ANOVA analysis. When 
using a t-test analysis, there was a significant difference between MTA with the 
control, modified-MTA with the control, and MTA and modified-MTA. The control 
group produced the highest amount of p-nitrophenol overall in 20 days of culture 
when compared to the MTA and MTA-Si group. 
Avera e concentration of -nitro henol in mM er 10 cells 
MT A MT A-Si Control 
4.02 ± 0.92 1.67 ± 0.77 30.67 ± 9.12 
Table 13. The average concentration of p-nitrophenol expressed over 20 
days of culture. 
Statistical Analysis P value 
ANOVA 1.31 X 10-6 
MTA vs. Control 0.004 
MTA-Si vs. Control 0.002 
MT A vs. MT A-Si 0.813 
Table 14. Statistical analysis of ALP over 20 days of culture . 
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Figure 8. ALP activity at 20 days of culture. Values shown are mean and 
standard deviations. 
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7. Osteocalcin expression at 12 days 
Osteocalcin expression was determined by the measurement of 125 I-labelled 
antibody attached to osteocalcin in extracted culture media. The amount of 
osteocalcin in culture was expressed per 102 cells. There was no statistical 
significant difference between the three groups, MTA, modified-MTA, and control 
group in regards to the expression of osteocalcin concentration under an ANOVA 
analysis. 
Osteocalcin concentration (in ng per 1 OL cells) 
MTA I MTA-Si I Control 
15.52± 3.20 I 16.65 ± 4.00 I 15.11 ± o.91 
ANOVA P= 0.579 
Table 15. The average amount of osteocalcin expressed at 12 days per 
102 cells exposed to MTA, modified-MT A, and control group. ANOVA 
comparison of the groups shows no significant difference (p=0.579). 
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Figure 9. Osteocalcin expression at 12 days of culture. Values shown 
are means and standard deviations. 
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8. Osteocalcin expression at 20 days 
Osteocalcin was observed at 20 days of culture. There was a significant 
difference between the three groups, MTA, modified-MT A, and control group 
when compared using ANOVA. A significant difference was found when using t-
test analysis between MTA and the control group, and MTA-Si and the control 
group. There was no significant difference between MTA and MTA-Si. 
Osteocalcin concentration (in ng per 1 OL cells) 
MTA MTA-Si Control 
13.13 ± 13.67 ± 2.84 10.47 ± 1.45 
2.16 
Table 16. The average amount of osteocalcin expressed per 102 cells 
exposed to MTA, modified-MT A, and control over 20 days of culture. 
Statistical Analysis P value 
ANOVA 0.032 
MT A vs. Control 0.015 
MTA-Si vs. Control 0.041 
MT A vs. MT A-Si 0.69 
Table 17. The statistical analysis of osteocalcin expression of cells 
exposed to MT A, modified-MT A, and control groups over 20 days of 
culture. 
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Figure 10. Osteocalcin expression at 20 days of culture. Values shown 
are means and standard deviations. 
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Discussion 
This in vitro study was designed to evaluate the effects of Silicon (Si) combined 
with Mineral Trioxide Aggregate (MTA) on the osteogenesis of normal human 
osteoblast cells. Normal human osteoblast cell lines were established and 
cultured at 16 hours, 12 days and 20 days with culture medium. Media pH, cell 
attachment efficiency, cell proliferation rate, alkaline phosphatase activity, and 
osteocalcin expression were examined. 
Previous studies have shown the role Silicon has in osteogenesis (Keeting PE et 
al., 1992). Keeting et al. demonstrated the effect of Silicon on the activity of 
osteoblast-like cells using a Silicon containing compound called Zeolite A. It was 
revealed that Silicon went into solution from the Zeolite A as silicic acid and this 
made a positive impact on cell activity as shown by the measurement of DNA 
synthesis and alkaline phosphatase activity. It has also been demonstrated that 
the induction of osteogenic activity with Silicon is dose-dependent (Chou Let al., 
1998). Therefore the higher the concentration of Silicon, the higher the 
expression of osteogenic activity. 
The pH of the culture medium in which the osteoblast cells were grown with 
MTA, modified-MT A, and in the absence of material ( control group) was 
observed. The pH in all of the three groups stayed within the physiologic range 
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of natural cell growth, which is between the range of 7.40 and 8.40. In this study, 
cells grown in the presence of MTA and modified-MT A had a slightly higher 
media pH than the cells in the control group. This could reflect the ions within the 
MTA and modified-MTA material that may have been leached out over time 
acting is a buffering capacity along with the existing culture medium that 
contained nutritional elements such as fetal bovine serum, and the CO2 buffer 
capacity provided by the incubator. Fetal bovine serum has been shown to 
provide nutritional supplementation as a role in the plasma buffer system (Chou L 
et al., 1998). CO2 enables the maintenance of a physiologic pH (Cockcroft DL, 
1978). 
Medium pH does have an effect on the cellular activities of the osteoblast cells 
grown in the presence of MTA and modified-MT A. This was demonstrated in 
previous studies where there was minimal ALP activity and unmineralized 
extracellular matrix at a pH of 7.9 (Chou L et al., 1998; El- Ghannan A, 1996). A 
study by Kaysinger et al. showed that the ALP activity and collagen expression of 
human osteoblast cells increased with increasing pH. It has been observed that 
at a pH range of 6.0 to 6.5 cell viability is lost, and at a pH values of 6.5 to 7.0 
cell growth stops. According to CT Hank et al. DNA and protein synthesis can be 
inhibited at an alkaline pH. In this study, for each of the three groups, the pH 
from day 1 to day 18 slightly decreased starting from an alkaline pH (8.40-MTA, 
8.09-modified-MTA , 7.99-control) to a slightly lower pH which was still within 
physiologic range (7.68-MTA, 7.79-modified-MTA, 7.42-control). There was a 
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slight increase of pH for all three groups from day 18 to day 20, with the addition 
of differentiation medium containing 1 ,25-dihydroxyvitamin 0 3. This slight 
increase can be attributed to the cellular effects of the osteoblast cells grown in 
the presence of MTA and modified-MT A, shifting from a proliferation state to a 
differentiation state. An increase in pH could reflect the deposition of calcium, 
and the initiation of mineralization due to the cells differentiating. 
Cell attachment efficiency 
Cell attachment was measured at 16 hours of culture after osteoblast cells were 
seeded in 24 well culture plates. The method used to measure attachment was 
the crystal violet dye method. Crystal violet is a basic dye with absorbance of 
589nm-593nm. It is used for cytotoxicity tests, and to detect cell numbers in a 
monolayer culture (Gillie RJ, 1986; Baer MR et al., 1986; Kueng Wet al., 1989). 
It is also used as a nuclear or chromatin stain and has been p~oven to stain 
protein like keratin in epithelial cell cultures (Gillies RJ, 1986; Lillie RD, 1969; 
Bonnekoh Bet al., 1989). 
The results of this study revealed that there was no significant difference in the 
16 hour attachment rate between the cells attached to MTA, modified-MT A, and 
the control group. Data shows that with a 15% addition of Silicon to MTA, there 
is not much of an effect on the attachment rate when compared to MTA alone or 
in the absence of MT A. Past literature indicated that surface topography can be 
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one of the factors that affect cell attachment rates (Chou Let al., 1995, 1998). 
Therefore, the attachment rate may be affected more by the surface topography 
than the composition of the material (MTA and Silicon). 
Cell Proliferation 
Previous studies have demonstrated the effect of Silicon on cell proliferation 
(Keeting PE et al., 1992; Matsuoka H, 1999). Silicon seemed to promote 
proliferation according to DNA content measurement. With the addition of Silicon 
to the medium, there was a positive contribution to cell activity, which was 
observed by the measurement of DNA synthesis, and alkaline phosphatase 
activity (Keeting PE et al., 1992). K Lyu et al. demonstrated that Silicon and 
other ions enhanced cell proliferation in a dose-dependent manner. In our study, 
at both 12 and 20 days, cells grown in the presence of MT A and modified-MT A 
exhibited an increase in proliferation rate, higher than the control group. This 
may support our belief that Silicon stimulates cell proliferation. With the addition 
of 15% Silicon the modified-MTA was compared to the original MTA, however, 
there was no statistical significance between the two groups. Since it has been 
demonstrated that Silicon may indeed be dose-dependent, a higher dose of 
Silicon added to MTA may yield a significant effect, enhancing the osteogenic 
effects of the material. Therefore, 15% addition of Silicon may not be the 
optimum concentration of Silicon for the MTA material, and a higher dose needs 
to be evaluated. 
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In previous reports, osteoblast cells have grown in the presence of MTA reaching 
a confluence at 144 hours (Koh ET et al., 1997). This is consistent with previous 
reports that osteoblast cell proliferation peaks around 12 and 18 days. 
Alkaline Phosphatase 
Many studies have demonstrated osteocalcin expression and alkaline 
phosphatase activity as measures of osteogenic activity in osteoblast cell lines. 
These are phenotypic bone markers used to identify and measure the 
developmental and differentiating sequence of osteoblast cells. 
ALP activity of osteoblast cells has been widely used to characterize and 
demonstrate osteogenic activity because it is a main feature of osteogenesis. It 
has been reported that ALP is involved in the mineralization process, however 
high ALP levels may be reflected in proteins produced by preosteoblasts and 
prior to the expression of non-collagenous proteins, both stages that occur before 
mineralization (Aubin J, 1999). 
At both 12 and 20 days of culture, the control group expressed statistically 
significantly higher ALP activity when compared to the MTA and modified-MTA 
groups. This could be because cells grown in the absence of material had 
differentiated earlier, around 12 days, reflecting a higher expression of ALP. The 
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cells grown on MTA and modified-MT A were comparable, and there was no 
significant difference between these two groups. ALP was still expressed, 
however in lower concentration. Therefore, both MTA and modified-MT A have 
an effect on the osteoblast to express ALP, but optimal expression for cells 
grown in the presence of MTA and modified-MTA may be at a later time period, 
past 20 days, and the cells have not differentiated at this time. Also, expression 
of ALP may be delayed, and expression is at a later period in the osteoblast cell 
time line. Optimal expression of ALP could occur after osteocalcin expression 
since osteocalcin expression of cells grown in the presence of MTA and 
modified-MTA was higher than in the control group . 
Osteocalcin Expression 
Osteocalcin is known to be regulated by vitamin D3 (Beresford JN et al., 1986). It 
is the main non-collagenous protein in adult bone. It appears to be produced by 
osteoblast cells and is involved in mineral deposition (Lian JB and Gundberg CM, 
1988). Osteocalcin is expressed postproliferatively with the onset of nodule 
formation. It is maximally expressed with mineralization of the extracellular 
matrix in vivo (Hauschka PV et al., 1989), and in vitro (Owen TA et al., 1990). It 
is expressed later in the osteoblast developmental sequence and is a marker for 
the mature osteoblast cell. 
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At 12 days of cell culture, it was observed that there was no significant difference 
between the cells grown in the presence of MTA, modified-MTA, and the control 
group. At 20 days of culture, there was a significant increase of osteocalcin 
expression in the MTA and modified-MTA group, with the modified- MTA 
expressing a slightly higher level of osteocalcin than the MTA group, but not at a 
level that was significant. Since there was higher expression of osteocalcin in 
both the MTA and the modified-MT A group when compared to the control group 
by day 20, and ALP expression of cells in the MTA and the modified-MTA group 
were lower than the control group for both 12 and 20 days, this indicates that 
osteocalcin expression may be earlier than ALP activity. Therefore, by day 12, 
osteocalcin is being expressed by the human osteoblast cells. By day 20, 
osteocalcin expression of cells grown in MTA and modified-MT A is significantly 
higher than the control group. This affirms that MTA and modified-MTA material 
contribute to activate a higher expression of osteocalcin, enabling the osteoblast 
cells to express a higher concentration of osteocalcin at day 20. This could 
inherently contribute to a greater amount of mineralization due to increased 
amounts of osteocalcin protein produced since in normal human osteoblast cells, 
the osteocalcin gene may be expressed or induced at high levels at the onset of 
extracellular matrix mineralization. 
Although osteocalcin was expressed by day 12 and continued to be expressed 
until day 20, the level of osteocalcin by day 20 may not be the maximal 
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expression of this protein. The fact that osteocalcin, a specific bone marker that 
verifies the phenotype for bone, is expressed by day 12 affirms the fact that the 
phenotype of the cells growing in the presence of MTA and modified-MT A is in 
fact osteoblast cells. Therefore a higher level of osteocalcin expression could be 
anticipated beyond 20 days of culture. 
The cells grown in the control group at day 12 and day 20 exhibited a higher ALP 
expression than those in the experimental groups because the osteoblast cells 
were at the differentiation stage. At day 20, the cells grown in the presence of 
MTA and modified-MTA may not have fully differentiated, while the cells grown in 
the control group had stopped proliferating and were differentiated. This is 
shown by the lower ALP levels the osteoblast cells produce in the MTA and 
modified-MTA groups (osteoblast cells are still proliferating) and the higher 
expression of osteocalcin than the control group at day 12. Both MTA and 
modified-MTA show a delay in ALP expression, therefore, it may be expressed 
later than osteocalcin. Osteocalcin may continue to be expressed at an even 
higher concentration, with more days of culture since osteocalcin is optimal with 
nodule formation and mineralization. 
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Conclusion 
1. Normal human osteoblast-like cell cultures were successfully 
characterized and established from human alveolar bone explants. 
2. Both MTA and modified-MTA (MTA containing 15% addition of Silicon) 
significantly stimulated cell attachment and proliferation at 12 and 20 days 
when compared to the human osteoblast cells grown in the control 
environment (plastic culture dish). 
3. Both MTA and modified-MTA demonstrated an increase in the expression 
of osteocalcin at late culture of 20 days. 
4. Both MTA and modified-MTA showed a delay expression of alkaline 
phosphatase activity in 20 days of culture . 
5. Modified-MTA (MTA containing 15% addition of Silicon) did not show a 
significant effect on cell attachment and proliferation when compared to 
conventional MT A. 
Based on the results of this in vitro study, it has been demonstrated that cells 
grown in the presence of MTA and modified-MTA adhere well to the material, 
and that they proliferate at a higher rate than cells grown in the absence of the 
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material. Cells grown in the presence of MTA and modified-MTA have a higher 
expression of osteocalcin when compared to cells grown in the absence of 
material (control group) over the same 20 days of culture. Cells grown in the 
presence of MTA and modified-MT A had delayed expression of alkaline 
phosphatase over 20 days of culture when compared to cells grown in the 
absence of material (control group). There was no significant difference between 
MTA and modified-MTA when comparing cell attachment, cell proliferation, 
alkaline phosphatase activity and osteocalcin expression. The performance of 
modified-MTA did not display a significant effect when compared to conventional 
MT A. This could be due to an insufficient concentration of Silicon since Silicon is 
known to be dose-dependent in nature (Chou L, et al. 1996). Therefore, in order 
for a significant effect to be seen, a higher concentration of Silicon would be 
needed. 
From this study, MTA and modified-MTA exhibit osteogenic effects on normal 
human osteoblast cells. These findings are supported by previous studies that 
MTA is biocompatible and that it stimulates osteoblast cell expression and 
growth. 
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FUTURE STUDIES 
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Future Studies 
This study demonstrated that MTA and modified-MTA, with the addition of 
Silicon, has an effect on normal human osteoblast cells. Successful culture with 
Modified-MT A showed that Silicon does not have a detrimental effect to cell 
growth and proliferation, nor does it inhibit the expression of osteocalcin since 
modified-MTA continues to allow cell growth, proliferation and expression of 
osteocalcin and alkaline phosphatase activity. Further studies need to be 
conducted to verify and demonstrate that Silicon is dose-dependent in nature, 
and that increasing the amount of Silicon added to conventional MTA may in fact 
improve the osteogenic effects of conventional MTA. Other modifications, such 
as the addition of Calcium and Phosphorus should be investigated in order to 
observe their effects on osteogenicity. 
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